Skip to main content

Table 2 SAIA-HTN study primary and secondary outcomes

From: Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial

Type Indicator Numerator Denominator
Process BP screening* # PLHIV in ambulatory care consults screened for BP # Ambulatory care consults for PLHIV
HTN Diagnosis # PLHIV with new or existing HTN diagnosis in ambulatory care consults # PLHIV in ambulatory care consults screened for BP
HTN Medication prescribed # PLHIV with new or existing HTN diagnosis prescribed HTN medication # PLHIV with new or existing HTN diagnosis in ambulatory care consults
HTN Medication pick up # PLHIV prescribed HTN medications who picked up their medications the previous month # PLHIV with new or existing HTN diagnosis prescribed HTN medication
Clinical Controlled HTN amongst those on treatment* # PLHIV with new or existing HTN diagnosis and taking HTN medications who have controlled HTN # PLHIV prescribed HTN medications who picked up their medications the previous month
Undetectable HIV viral load # PLHIV with HTN and a non-detectable HIV viral load # PLHIV with HTN
  1. Bolded and *= primary outcome; BP blood pressure, PLHIV people living with HIV, HIV human immunodeficiency virus, HTN hypertension